Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)
Pulse Biosciences' (PLSE) quarterly Finished Goods came in at $750000.0 in Q3 2022, down 55.91% year-on-year from $1.7 million in Q3 2021, and down 71.0% quarter-over-quarter from $2.6 million in Q2 2022.
Pulse Biosciences (PLSE) Finished Goods (2021 - 2022) Analysis & Trends
Pulse Biosciences' Finished Goods history runs 2 years deep, the most recent figure standing at $750000.0 for Q3 2022.
- On a quarterly basis, Finished Goods fell 55.91% year-over-year to $750000.0 in Q3 2022; TTM through Sep 2022 was $750000.0, a 55.91% decrease from a year earlier, with the FY2021 full-year figure at $2.4 million, changed N/A from the prior year.
- Finished Goods slipped to $750000.0 in Q3 2022 per PLSE's latest filing, from $2.6 million in the prior quarter.
- Across five years, Finished Goods topped out at $2.7 million in Q1 2022 and bottomed at $750000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 2.74 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | 1.70 Mn |